Abstract 1602: Development and validation of an NGS-based assay to detect all classes of genomic alterations in circulating tumor cells (CTCs) from patients with solid tumors
Allison W. Welsh(Yale University), Philip J. Stephens(United States Department of the Navy), Doron Lipson(Genomics (United Kingdom)), Hannah M. Pezzi(University of Wisconsin–Madison), Zachary R. Chalmers(Northwestern University), Jamie M. Sperger(University of Wisconsin–Madison), Geoff Otto(Foundation Medicine (United States)), Anne M. Traynor(University of Wisconsin Carbone Cancer Center), Roman Yelensky(National Vaccine and Serum Institute), Lindsay N. Strotman(University of Wisconsin–Madison), Scott M. Berry(John Innes Centre), Vincent A. Miller(Universidad San Carlos), Garrett M. Frampton(Tech Foundation), Joshua M. Lang(University of Wisconsin–Madison)
Cited by 0
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
|Genome Medicine|2017|3.7k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k